Australian biotech market today 23.04.09
Thursday, 23 April, 2009
A very flat day’s trading on the healthcare index today, in line with the rest of stocks, which were generally in the positive but volumes were small.
Biota (ASX:BTA) is up 12c on news that royalties from Relenza for the quarter will total $32.3 million.
Circadian (ASX:CIR) was up 3c, as was Clinuvel (ASX:CLV), up 2c to 32c.
Cochlear (ASX:COH) was substantially down again, to $48.3, while Pharmaxis (ASX:PXS) was up a touch.
Diversa (ASX:DVA) was up slightly on its reinstatement to trading.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
